IP Library Granted Patent US 8,580,985
Granted Patent B2
US 8,580,985 · App. 13/707,480 · Granted Nov 12, 2013

Processes for preparing estolide base oils and oligomeric compounds that include cross metathesis

Inventors: Travis Thompson (Anaheim, CA); Kelly Parson (Irvine, CA); Jakob Bredsguard (Irvine, CA); Jeremy Forest (Irvine, CA)
Assignee: Biosynthetic Technologies, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,580,985
App. No.
13/707,480
Granted
Nov 12, 2013
Kind
B2
Abstract

Provided herein are estolide base oils and oligomeric compounds prepared from processes that include cross metathesis. Exemplary processes include the preparation of terminally-unsaturated fatty acids by cross metathesis, and the subsequent oligomerization of terminally-unsaturated fatty acids to provide estolide compounds, such as the process set forth below:

Claims (32)

1. A process of producing an estolide base oil comprising:

providing at least one triglyceride having at least one oleic acid residue;

providing at least one alpha olefin selected from one or more of ethene, propene, 1-butene, 1-pentene, 1-hexene, 1-heptene, or 1-octene;

contacting the at least one triglyceride with the at least one alpha olefin in the presence of a metathesis catalyst to provide an olefin product comprising 1-decene, and a metathesized fatty acid product comprising at least one 9-decenoic acid residue;

hydrolyzing the metathesized fatty acid product to provide a free fatty acid product comprising 9-decenoic acid;

providing an oligomerization catalyst; and

oligomerizing the 9-decenoic acid with a second fatty acid in the presence of the oligomerization catalyst to produce an estolide base oil, wherein said oligomerizing comprises forming a covalent bond between an oxygen of a carboxylic group of the second fatty acid and a carbon of the double bond of the 9-decenoic acid.

2. The process according to claim 1 , wherein the oligomerization catalyst is selected from a Bronsted acid and a Lewis acid.

3. The process according to claim 1 , wherein the oligomerization catalyst is a Bronsted acid.

4. The process according to claim 1 , wherein the metathesis catalyst is an osmium or ruthenium alkylidene metathesis catalyst.

5. The process according to claim 1 , further comprising esterifying the resulting estolide base oil with at least one alcohol to provide an esterified estolide base oil.

6. At least one compound according to Formula III:

wherein

n is an integer selected from 0 to 20;

R 1 is an unsubstituted, branched or unbranched C 7 to C 17 alkyl that is saturated or unsaturated;

R 2 is an unsubstituted C 1 to C 22 alkyl that is saturated or unsaturated, and branched or unbranched; and

R 3 and R 4 , independently for each occurrence, are selected from

wherein R 3 and R 4 are unsubstituted and z is 7.

7. The process according to claim 1 , wherein the at least one alpha olefin is 1-butene.

8. The process according to claim 7 , wherein the olefin product further comprises 3-dodecene.

9. The process according to claim 7 , wherein the free fatty acid product further comprises 9-dodecenoic acid.

10. The process according to claim 1 , wherein the at least one alpha olefin is ethene.

11. The process according to claim 10 , wherein the olefin product consists essentially of 1-decene.

12. The process according to claim 10 , wherein the free fatty acid product consists essentially of 9-decenoic acid.

13. The process according to claim 1 , wherein the second fatty acid is a saturated fatty acid or an unsaturated fatty acid.

14. The process according to claim 13 , wherein the second fatty acid is 9-decenoic acid.

15. The at least one compound according to claim 6 , wherein R 1 is selected from the structure of Formula IV:

wherein w is an integer selected from 5 to 7.

16. The at least one compound according to claim 6 , wherein R 1 is saturated and unbranched.

17. The at least one compound according to claim 6 , wherein R 2 is an unsubstituted, branched or unbranched C 1 to C 18 alkyl that is saturated or unsaturated.

18. The at least one compound according to claim 17 , wherein R 2 is branched and saturated.

19. The at least one compound according to claim 6 , wherein n is an integer selected from 0 to 12.

Assignments (9)
ASSIGNMENT OF SECURITY INTEREST Recorded Mar 23, 2018
From: BP TECHNOLOGY VENTURES INC.
To: BIOSYN HOLDINGS, LLC
Reel/Frame 045688/0600 →
ASSIGNMENT OF SECURITY INTEREST Recorded Mar 23, 2018
From: EVONIK CORPORATION
To: BIOSYN HOLDINGS, LLC
Reel/Frame 045860/0547 →
ASSIGNMENT OF SECURITY INTEREST Recorded Mar 23, 2018
From: EVONIK OIL ADDITIVES USA, INC.
To: BIOSYN HOLDINGS, LLC
Reel/Frame 045684/0293 →
RELEASE OF SECURITY INTEREST Recorded Feb 13, 2018
From: SILICON VALLEY BANK
To: BIOSYNTHETIC TECHNOLOGIES, LLC
Reel/Frame 044916/0936 →
SECURITY INTEREST Recorded Jan 30, 2018
From: BIOSYNTHETIC TECHNOLOGIES, LLC
To: BP TECHNOLOGY VENTURES INC.
Reel/Frame 045196/0587 →
SECURITY INTEREST Recorded Mar 18, 2016
From: BIOSYNTHETIC TECHNOLOGIES, LLC
To: EVONIK OIL ADDITIVES USA, INC.
Reel/Frame 038146/0859 →
SECURITY INTEREST Recorded Nov 30, 2015
From: BIOSYNTHETIC TECHNOLOGIES, LLC
To: EVONIK CORPORATION
Reel/Frame 037162/0364 →
SECURITY INTEREST Recorded Dec 20, 2014
From: BIOSYNTHETIC TECHNOLOGIES, LLC
To: SILICON VALLEY BANK
Reel/Frame 034562/0322 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2013
From: THOMPSON, TRAVIS; PARSON, KELLY; BREDSGUARD, JAKOB; FOREST, JEREMY
To: BIOSYNTHETIC TECHNOLOGIES, LLC
Reel/Frame 030469/0749 →
Continuity (3)
Provisional Application 61577598 · Dec 19, 2011
Provisional Application 61610376 · Mar 13, 2012
Related Publication 20130158277A1 · Jun 20, 2013